ILCA
@ILCAnews
Followers
3K
Following
996
Media
1K
Statuses
2K
The International Liver Cancer Association (ILCA) is the only international organisation devoted to liver cancer for experts from all related disciplines.
Brussels, Belgium
Joined April 2012
Decisions about #HCC care should never be made alone. Shared decision-making empowers patients & clinicians to choose treatments that align with medical needs AND personal values. Let’s make it the norm. Read more in Patient Charter: https://t.co/qBplp1UQRi
0
3
7
Every expert was once a learner, and every breakthrough begins with shared knowledge. ILCA’s Mentorship Programme connects experts with emerging researchers in liver cancer care, because progress starts when we learn from each other. 🎓Become a mentor: https://t.co/aCgkaE7w2j
0
1
3
Multidisciplinary teams are shaping the future of liver cancer care. The first #ILCASchool in India is a turning point where global expertise meets regional talent. Join us and @INASL_Liver on Dec 19–20 in Gurugram👉 https://t.co/L2U4gDMBkT
1
3
5
Biomarkers are key for early detection and personalized HCC treatment, but better tools are urgently needed. ILCA’s guidance offers clear recommendations to advance research. Explore: https://t.co/YOj1FZrJ7f Next week we look into Systemic Therapy Guidance 🎓
0
0
2
No one-size-fits-all in #HCC care. Personalized treatment means tailoring plans to medical needs AND personal context. Tailored care leads to better outcomes, improved quality of life, and greater trust. Read more in Principle 4 of the Patient Charter: https://t.co/6ntRkneBN9
0
2
3
To grow our community of researchers, scientists, and physicians, all participants based in India will receive a complementary one year ILCA Membership in 2026! https://t.co/pINGcqJ6fV
@INASL_Liver
0
1
2
Liver cancer call for a community without borders. That’s why ILCA is bringing its School to India for the first time, in collaboration with @INASL_Liver. https://t.co/RO2Ig4PHw0
1
0
0
TACE is key for intermediate-stage HCC but how do we ensure its use is evidence-based? The ILCA TACE Consensus Guidance offers practical recommendations from a multi-disciplinary team to optimize patient care. Explore it here: https://t.co/5hAANWAvBP
0
2
5
The future of liver cancer research depends on the connections we build today. The ILCA Mentorship Programme is here to make those connections happen. If you're ready to become a mentor and share your knowledge and experience, start here: https://t.co/PJX5pdyiXV
@siadaniela
0
2
6
Ready to see the future of liver cancer care? The #ILCA @INASL_Liver School of Liver Cancer, brings global & local experts together for 2 days of learning - covering: Liver Cancer in India, Biology clinicians need, Challenging CCA cases and more... https://t.co/L2U4gDM3vl
0
0
0
CAR-T cell therapy in hepatocellular carcinoma: from mechanistic insights to clinical translation Cancer Treatment Reviews https://t.co/1eRseKpHeZ 🧐Interesting review on CAR-T cells, the next big wave? @myESMO @EASLedu @ILCAnews
3
33
77
Great learning @ILCAnews HK and APDW Singapore. The best talk was on pall care by Dr Ken Liu. We need more studies. @ajay_duseja @AnjanaPillaiMD @DrAshish_Kumar do attend ILCA @INASL_Liver school this month at Gurugram
0
4
19
ILCA School of Liver Cancer is a space where ideas turn into practice. As an ILCA member you can join us at discounted rates and make new connections. Not a member yet? Join the community https://t.co/RLXL2ieM7S
1
4
6
Care takes a team. Multidisciplinary support in #HCC care: hepatologists, oncologists, radiologists and more, improves outcomes and patient experience. How can we make this standard everywhere? 📖 https://t.co/6ntRkneBN9
0
1
1
Thank you to the #ILCA25 program committee @docamitgs @ma5RN @AnjanaPillaiMD @A_DAlessioMD @allaire_manon @StephenLChan1 @AmaiaLujambio, our speakers, attendees and sponsors for creating a space where we can discuss, learn and advance #livercancer care.
0
1
4
At #ILCASchool we're uniting experts because when multidisciplinary disciplines unite, the patients win. https://t.co/L2U4gDM3vl
@docamitgs
0
0
0
What a pleasure to co-chair the #ILCA25 session on systemic therapy in HCC and CCA with @LorenzaRimassa 💊 Great debate on trial design in neoadj HCC, novel treatment strategies for HCC, the present and future of CCA therapies 🩺 @StephenLChan1 @ILCAnews
0
5
17